Editorial: Turning Point towards Blood Biomarker-Guided Targeted Therapy for Precision Medicine in Alzheimer's disease.

Hampel, H; Vergallo, A; Bonuccelli, U; Lista, S

Hampel, H; Vergallo, A; Bonuccelli, U; Lista, S.

Afiliação

Hampel H; Harald Hampel, MD, PhD, MA, MSc, AXA Research Fund and Sorbonne University Chair, Sorbonne University, Department of Neurology, Institute of Memory and Alzheimer's Disease (IM2A), Brain and Spine Institute (ICM), François Lhermitte Building, Pitié-Salpêtrière Hospital, 47 Boulevard de l'hôpital, 75651 Paris CEDEX 13, France, Phone : +33 1 42 16 75 15, Fax: +33 1 42 16 75 16, E-Mail: harald.hampel@icm-institute.org.

J Prev Alzheimers Dis ; 5(3): 160-164, 2018.

Article em En | MEDLINE | ID: mdl-29972206

Assuntos

Doença de Alzheimer/sangue; Biomarcadores/sangue; Medicina de Precisão/métodos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Medicina de Precisão / Doença de Alzheimer Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google